We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
136 hedge funds and large institutions have $277M invested in Larimar Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
834% more call options, than puts
Call options by funds: $682K | Put options by funds: $73K
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
2% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 44
1% more capital invested
Capital invested by funds: $275M → $277M (+$2.2M)
0% more funds holding
Funds holding: 136 → 136 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14.95% less ownership
Funds ownership: 99.89% → 84.95% (-15%)
Holders
136
Holders Change
–
Holders Change %
0%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
22
Increased
45
Reduced
44
Closed
19
Calls
$682K
Puts
$73K
Net Calls
+$609K
Net Calls Change
-$20M
Top Buyers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.89M |
| 2 |
BOCH
Blue Owl Capital Holdings
New York
|
+$3.78M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.7M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.39M |
| 5 |
BlackRock
New York
|
+$1.33M |
